# DCB Under the Guidance of OCT in STEMI

Study · id `cardio:ct-nct05680051` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05680051](<https://clinicaltrials.gov/study/NCT05680051>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05680051

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT05680051. Randomized; no masking; primary purpose treatment. Start 2023-01-30 (actual); primary completion 2024-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT05680051, source copy `cardio:ctgov-nct05680051-2023-03-24`, retrieved 2026-10-26)
- Started: 2023-01-30 (actual) (ClinicalTrials.gov record NCT05680051, source copy `cardio:ctgov-nct05680051-2023-03-24`, retrieved 2026-10-26)
- Primary completion: 2024-12-30 (anticipated) (ClinicalTrials.gov record NCT05680051, source copy `cardio:ctgov-nct05680051-2023-03-24`, retrieved 2026-10-26)
- Completion: 2025-02-28 (anticipated) (ClinicalTrials.gov record NCT05680051, source copy `cardio:ctgov-nct05680051-2023-03-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05680051, source copy `cardio:ctgov-nct05680051-2023-03-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05680051-2023-03-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: DCB Under the Guidance of OCT in STEMI
- Condition: Acute ST-segment Elevation Myocardial Infarction
- Intervention (Device): Drug-eluting balloon
- Intervention (Device): Drug-eluting stent
- Lead sponsor: Henan Institute of Cardiovascular Epidemiology
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Henan Institute of Cardiovascular Epidemiology (`cardio:org-henan-institute-of-cardiovascular-epidemiology`)

## Provenance

Content hash: 023a805134e1bfe15ec39b68ec8b965ba99125aff7a9824335705dd23ce8cbf9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
